MedPath

"THE CLINICAL TRIAL TO STUDY THE EFFECT OF TWO DRUGS ADRAKAKHANDA AND HARIDRAKHANDA IN THE MANAGEMENT OF SHEETPITTA (URTICARIA)"

Completed
Conditions
SHEETPITTA
Registration Number
CTRI/2015/08/006073
Lead Sponsor
GOVT AKHANDANAND AYURVED COLLEGE
Brief Summary

This study is a randomised, Participant blinded, parallel group, active controlled trial to compare the efficacy of **Adrakakhanda in the Dose of 6 gram OD with vehicle of Usnodaka for the duration of 1 month in 17 Patients of Sheetpitta** and**Haridrakhanda****in the Dose of 6 gram OD with vehicle of Usnodaka for the duration of 1 month****in 17 Patients****of Sheetpitta** will be conducted in India.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
34
Inclusion Criteria
  • The patients will be selected on the basis of classical sign and symptoms of SHEETPITTA described in ayurved classics like....
  • Varti Damshta Samsthana Shotha, Kandu, Toda, Vidaha, Mandala, Kshanikotpattivinash.
Exclusion Criteria

Disease like Giant urticaria, Angioedema, Diabetes mellitus, T.B., and other systemic disorder which leads fatal condition for patient.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
All the signs and symptoms of Sheetpitta will be assigned score depending upone their severity to assess the effect of the drugs at the time of Before treatment and After treatment.1 month
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

(1) GOVT AKHANDANAND AYURVED HOSPITAL ,AHMEDABAD (2) GOVT MANIBEN AYURVED HOSPITAL, AHMEDABAD

🇮🇳

Ahmadabad, GUJARAT, India

(1) GOVT AKHANDANAND AYURVED HOSPITAL ,AHMEDABAD (2) GOVT MANIBEN AYURVED HOSPITAL, AHMEDABAD
🇮🇳Ahmadabad, GUJARAT, India
MR DHARMESHKUMAR JAYANTILAL PATEL
Principal investigator
09925098555
dr.dharmeshpatel@ymail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.